WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan […]
Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery and development RADNOR, PA – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer. In this role, Bouton will lead technology […]
SepSolve Analytical and Markes International (companies of Schauenburg Analytics Ltd) are pleased to announce the appointment of Gareth Davies as Chief Financial Officer (CFO), strengthening the leadership team as both companies continue their international growth. Gareth joins from Lightico, a provider of digital tools for the financial services and telecoms sectors. He brings a strong […]
Markes International and SepSolve Analytical (companies of Schauenburg Analytics Ltd) are pleased to announce the appointment of Gareth Davies as Chief Financial Officer (CFO), strengthening the leadership team as both companies continue their international growth. Gareth joins from Lightico, a provider of digital tools for the financial services and telecoms sectors. He brings a strong […]
Industry Veteran and Former Pfizer Chief Scientific Officer Brings Extensive R&D and Leadership Experience to Advance BenchSci’s Mission of Improving the Speed and Quality of Preclinical R&D TORONTO–BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors. Dr. Dolsten, […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad’s global commercial strategy and execution, succeeding Mike Crowley, who is […]
Jim Meyer to Become Chief Financial Officer, Effective March 1, 2026 WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company’s board of directors […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial Officer of the Company’s Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher’s Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, […]
Seasoned Executive with Proven Track Record of Value Creation in Life Sciences RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025. […]
ZEISS Group recently announced that Martin Fischer will officially take on the role of President and CEO of ZEISS Greater China, effective from October 1, 2025, reporting directly to Andreas Pecher, President and CEO of the ZEISS Group. Martin Fischer succeeds Maximilian Foerst, who joined the Executive Board of the ZEISS Group as the President […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

